Often, the industry's conflict of interest is apparent rather than subtle since disease prevention, non-drug-dependent methods lack commercial interest, as healthy people have little-to-no dependency and are not lucrative clients for the medication industry (279)
"I have said throughout this process that you do not solve a quality problem by forcing the market underground." "I was encouraged by the committees recommendation because it creates an opportunity to move patients away from unverified research use only (RUO), otherwise known as grey market products, and toward a more accountable medical pathway." LaValle said his work with the International Peptide Society focuses on training clinicians about the potential benefits and risks of peptide therapies as interest in the compounds grows
MEET THE NEW METHYLATION+ GENETIC TEST The new Methylation+ Genetic Test reads 27 genes across 6 connected body systems and turns what it finds into a plan built for the genes you actually have
But as a standalone agent, Retatrutide outperforms Cagrilintide by a factor of nearly 2.5x
The weight loss, comprehensive metabolic benefits, liver fat normalization, and triple-receptor activation make it the most potent standalone metabolic optimization agent weve seen in clinical trials to date
Polymerdrug conjugate therapeutics: advances, insights and prospects